HGH Fragment 176-191 Driada Medical EU
- Brand: Driada Medical EU
⚠️ WARNING: Potential Risks of Anabolic Steroids
Anabolic steroids can cause hormonal imbalances, liver strain, cardiovascular issues, and psychological effects, and should only be used under strict medical supervision. Unauthorized or improper use may lead to serious health complications.
If used, obtain these substances exclusively from licensed, verified medical providers to ensure safety and proper oversight.
HGH Fragment 176-191 Driada Medical EU
HGH Fragment 176-191 by Driada Medical is a stabilized, synthetic segment of the natural Human Growth Hormone (HGH) molecule. Specifically engineered to isolate the fat-burning properties of HGH, this peptide targets adipose tissue without the systemic growth effects or insulin sensitivity issues associated with the full-length hormone.
Available in a 5 mg vial, HGH Fragment 176-191 is a premier choice for researchers and athletes focused on body recomposition and targeted lipolysis.
Technical Product Specifications
| Feature | Detail |
| Product Name | HGH Fragment 176-191 |
| Manufacturer | Driada Medical |
| Active Substance | Recombinant HGH Fragment 176-191 |
| Concentration | 5 mg per Vial |
| Presentation | 1 Vial + Sterile Water for Reconstitution |
| Classification | Synthetic Peptide / Targeted Fat Oxidizer |
Core Benefits & Physiological Impact
HGH Fragment 176-191 is distinguished by its ability to manipulate fat metabolism with high specificity:
Direct Lipolysis Activation: The 176-191 sequence effectively triggers the breakdown of stored fat in adipose tissue.
Glycemic Safety: Unlike full-spectrum HGH, this fragment does not cause blood sugar disruption or decrease insulin sensitivity.
Isolated Metabolic Action: It mimics the fat-burning mechanism of HGH but avoids the cellular growth (hyperplasia) and organ growth effects of the complete molecule.
Enhanced Body Recomposition: It is a precision tool designed to oxidize stubborn body fat while preserving lean tissue.
Optimal Administration & Research Protocols
To maximize the fat-oxidizing potential of HGH Fragment 176-191, strict adherence to timing and blood glucose management is required:
Recommended Dosage: A daily total of 250–500 mcg.
Injection Frequency: For stable blood levels, the daily dose should be split into 3–4 subcutaneous injections.
The Fasting Rule: Injections are most effective during fasting periods or pre-cardio. Low insulin levels are critical for the peptide to successfully mobilize fat.
Cycle Duration: A minimum of 12 weeks of consistent use is generally required to observe significant results.
Preparation: The 5 mg lyophilized powder must be reconstituted with the provided sterile water and stored in a refrigerator.
Safety and Comparative Advantages
Side Effect Profile: Noted for having a significantly lower risk of adverse effects compared to Somatropin (HGH).
Cost Efficiency: Offers a more budget-friendly approach to fat loss for those who do not require the muscle-building or anti-aging benefits of full HGH.
Purity: Manufactured under rigorous quality control standards to ensure the highest purity for research applications.
